Navigation Links
Peripheral Vascular Device Market Insights Webinar
Date:6/2/2008


WALTHAM, Mass., June 2 /PRNewswire/ --

WHAT: PERIPHERAL VASCULAR DEVICE MARKET INSIGHTS WEBINAR

(audio and online presentation)

WHEN: Thursday, June 5, 2008, 11 am US Eastern Time, 5 pm Central

European Time (Paris)

PRESENTER: Stephanie LaBelle, Analyst from Millennium Research Group

TO ENROLL: Please use the link below to register or call Shiu-Yik Au at

416-364-7776 ext. 123

Millennium Research Group presents a complimentary Webinar outlining our knowledge of the peripheral vascular (PV) device industry. Sign up to gain information derived from our Global Peripheral Vascular Device report series and PV Marketrack(TM).

In this one-hour presentation, our Analyst will discuss numerous PV device market dynamics, including the following:

PV Market Trends

-- Global overview of the PV device market

-- Market focus: Factors included in the US market forecast models

PV Stent Market

-- Effect of indication-specific approvals on the use of stents

-- Highlights of PV practice trends for interventional cardiologists,

interventional radiologists, and vascular surgeons

Inferior Vena Cava Filter Market

-- Market impact of product developments and launches by existing and new

competitors

-- Results of supportive clinical data on device usage patterns

Thoracic Endovascular Aortic Repair (TEVAR) Market

-- Market impact of emerging competitors

A question and answer session will follow the presentation.

To enroll for this event, please use the Internet URL below to reach our WebEx page and then click the "Register" button at the bottom of the page. Once you complete the brief registration form, click "Submit".

https://mrg.webex.com/mrg/onstage/g.php?t=a&d=71415637
'/>"/>

SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults
2. Vermillions Roundtable Teleconference Highlights Peripheral Artery Disease Diagnostic Program; Features Commentary from Vascular Medicine Expert
3. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
4. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
5. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
6. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
7. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
8. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
9. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
10. Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System
11. Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, a
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
(Date:12/2/2009)HOBOKEN, N.J., Dec. 2 According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopat
(Date:12/1/2009)INCLINE VILLAGE, Nev., Dec. 1 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 million, as compared with
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...Oct. 29 Ventaira Pharmaceuticals,announced today ...t leader,will acquire Ventaira,s assets and assist...ms of the acquisition were not disclosed. "We wil...s. In,addition, we will work closely with Battelle...yees," said Leslie Williams, President and CEO,of ...
..., Oct. 29 TorreyPines Therapeutics,Inc. (Nasdaq: ...dent and,Chief Executive Officer of TorreyPines, w...9th Annual Healthcare Conference in New York on Mo...t of Dr. Kurtz,s presentation will be available li...reypinestherapeutics.com . An archived version,of ...
..., Oct. 29 Immunosyn,Corporation (OTC Bulletin Boa...d Criner as the company,s Chief Financial and Acco... and Accounting Officer, Douglas A.,McCain, Jr., h... Board and,further retains his position as Corpora...logy and its resulting,biopharmaceutical product c...
Other Biology Technology:Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle 2Immunosyn Corporation Names G. David Criner as CFO 2
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 53683 1Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 53683 2Neuropathic pain 3A The sea provides a new hope of relief 9475 1Neuropathic pain 3A The sea provides a new hope of relief 9475 2Demi Lovato Joins National Bullying Prevention Movement 53681 1Demi Lovato Joins National Bullying Prevention Movement 53681 2
...maceuticals, Inc. today announced that it has been...vation Research Grant (SBIR) from the National Ins... Institutes of Health (NIH) to develop in vivo zeb...rome (CYP) P450s. CYP profiling, a critical step ...rug Administration (FDA) for all new drug approval...
...the University of Florida, has donated $250,000 to...e establishment of an endowment to award creative ... find alternative solutions to problems that signi...t from the $250,000 will be presented to the winne...Innovation and Creativity in Entomology. , "I wan...
...is. Pop culture heedlessly and wrongly lumps th... paleontologists assumed that because the creature...sing only two legs to take flight. , Now comes...aunching some 500 pounds of reptilian heft into fl...re ultra-strong wings which, when folded and balan...
Other Biology News:NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays 2Florida professor creates endowment for insect scientists 2Four, three, two, one . . . pterosaurs have lift off 2
Mouse Anti-hnRNP F / H Monoclonal Antibody, Unconjugated, Clone 1G11 from Novus Biologicals
Rabbit Anti-Human Reptin / TIP49B / RUVB2 Polyclonal Antibody, Unconjugated from Abcam
Anti-Jak3 Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Human XPC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: